Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
A2586 Nafamostat Mesylate(FUT-175)Summary: Serine protease inhibitor
-
A2587 PMSF1 CitationTarget: Serine ProteasesSummary: Serine proteinases inhibitor, irreversible
-
A2573 AEBSF.HCl1 CitationTarget: Serine ProteasesSummary: Serine protease inhibitor
-
A2574 Aprotinin1 CitationTarget: Trypsin|Chymotrypsin|Kallikrein|TrypsinogenSummary: Inhibitor of bovine pancreatic trypsin
-
A2570 Leupeptin, MicrobialTarget: Cathepsins|Calpains|TrypsinsSummary: Inhibitor of serine and cysteine proteases
-
C3393 PPACKII (trifluoroacetate salt)Summary: glandular and plasma kallikreins inhibitor
-
C4437 UCF 101Summary: inhibitor of the proteolytic activity of Omi/HtrA2
-
C5839 Tosyllysine Chloromethyl Ketone (hydrochloride)Summary: serine proteinases inhibitor
-
C5589 ChymostatinSummary: chymotryptase-like serine proteases inhibitor